Standout Papers

Terlipressin plus Albumin for ... 2010 2026 2015 2020 826
  1. Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome (2021)
    Florence Wong, S. Chris Pappas et al. New England Journal of Medicine
  2. Rifaximin Treatment in Hepatic Encephalopathy (2010)
    Nathan M. Bass, Kevin D. Mullen et al. New England Journal of Medicine

Immediate Impact

2 from Science/Nature 72 standout
Sub-graph 1 of 18

Citing Papers

Cell death
2024 Standout
Liver Fibrosis: From Basic Science towards Clinical Progress, Focusing on the Central Role of Hepatic Stellate Cells
2024 Standout
3 intermediate papers

Works of R. Todd Frederick being referenced

Emricasan Improves Liver Function in Patients With Cirrhosis and High Model for End-Stage Liver Disease Scores Compared With Placebo
2018
Rifaximin Treatment in Hepatic Encephalopathy
2010 Standout

Author Peers

Author Last Decade Papers Cites
R. Todd Frederick 1319 1243 734 27 1.7k
Donald J. Hillebrand 1138 1101 554 23 1.6k
Rosa María Pérez‐Ayuso 1208 1201 764 31 1.9k
J Turcotte 1112 981 524 19 2.0k
Todd R. Stravitz 1623 1283 769 16 2.0k
D B Jones 1010 1042 565 37 2.2k
Joaquím Balanzó 1488 1347 1151 26 2.1k
Yang‐Te Tsai 1455 1384 502 61 2.0k
Juan J. Cabrera 778 687 631 49 1.6k
Muhammad Y. Sheikh 1282 1293 634 19 1.7k
Michael Schepke 1305 1230 1086 64 2.2k

All Works

Loading papers...

Rankless by CCL
2026